MADRIGAL PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Madrigal Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Madrigal Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 21.8M shares, a 17.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 21.8M +3.31M +17.9% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 19.9M +1.42M +7.67% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 19.9M +1.59M +8.71% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 19.9M +1.77M +9.79% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 18.5M +1.39M +8.13% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 18.5M +1.36M +7.93% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 18.3M +1.18M +6.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 18.1M +999K +5.84% Dec 31, 2022 10-K 2024-02-28
Q3 2022 17.1M +243K +1.44% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 17.1M +504K +3.04% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 17.1M +1.04M +6.48% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 17.1M +1.6M +10.3% Dec 31, 2021 10-K/A 2023-03-03
Q3 2021 16.9M +1.39M +9.01% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 16.6M +1.16M +7.52% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 16.1M +634K +4.11% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 15.5M +79K +0.51% Dec 31, 2020 10-K 2022-02-24
Q3 2020 15.5M +37.3K +0.24% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 15.4M +11.8K +0.08% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15.4M +12.1K +0.08% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 15.4M +20.1K +0.13% Dec 31, 2019 10-K 2021-02-25
Q3 2019 15.4M +35.8K +0.23% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 15.4M +60.9K +0.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 15.4M +1.17M +8.18% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 15.4M +1.18M +8.3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 15.4M +2.9M +23.2% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 15.4M +2.87M +23% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 14.3M +2.08M +17.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 14.2M +2.28M +19% Dec 31, 2017 10-K 2019-02-27
Q3 2017 12.5M +926K +8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 12.5M -125M -90.9% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 12.2M -126M -91.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 12M +11.8M +6685% Dec 31, 2016 10-K 2018-03-13
Q3 2016 11.6M -126M -91.6% Sep 30, 2016 10-Q/A 2017-03-31
Q2 2016 138M +3.73M +2.79% Jun 30, 2016 10-Q 2016-07-20
Q1 2016 138M +28.7M +26.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 176K -109M -99.8% Dec 31, 2015 10-Q/A 2017-03-31
Q3 2015 138M +28.9M +26.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 134M +32.8M +32.3% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 109M +21.5M +24.6% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 109M +23.9M +28% Dec 31, 2014 10-K 2016-03-15
Q3 2014 109M +39.8M +57.6% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 101M +32.3M +46.7% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 87.6M +18.5M +26.7% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 85.2M +16.3M +23.7% Dec 31, 2013 10-K 2015-03-12
Q3 2013 69.1M +7.22M +11.7% Sep 30, 2013 10-Q 2013-11-04
Q2 2013 69.1M +11.2M +19.5% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 69.1M +11.5M +19.9% Mar 31, 2013 10-Q 2013-04-30
Q4 2012 68.9M +19.4M +39.1% Dec 31, 2012 10-K 2014-03-11
Q3 2012 61.9M +12.4M +25% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 57.8M +8.34M +16.9% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 57.6M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 49.5M +7.45M +17.7% Dec 31, 2011 10-K 2013-03-14
Q3 2011 49.5M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 49.5M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 42.1M Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.